Evonik Industries

Evonik Industries AG is a publicly traded German specialty chemicals company with a mission to provide decisive competitive advantages through innovative, sustainable solutions. Its strategic focus, 'Leading Beyond Chemistry,' is executed through deep customer collaboration across three core segments: Nutrition & Care, Specialty Additives, and Smart Materials. The company has established itself as a key partner in the biotech ecosystem, particularly as a leading supplier of lipid nanoparticles for mRNA therapies and a provider of essential bioprocessing and synthetic biology solutions. Evonik meets its financial guidance and maintains a robust innovation pipeline to drive future growth.

Integrated platform combining specialty chemistry and biotechnology for drug delivery (lipid nanoparticles), bioprocessing, synthetic biology (biosurfactants), and advanced biomaterials.

Competes with Merck KGaA and pure-play firms in LNPs and bioprocessing; with BASF and DSM in biosolutions; and with Covestro in medical polymers. Key advantages are integrated chem/bio expertise, global scale, and strong sustainability focus.